TAVERAS ARTHUR (Chief Scientific Officer) reported 1 transaction at X4 PHARMACEUTICALS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 2/14/2022ACC: 0001628280-22-002507
Officer· Chief Scientific Officer
Since Nov 2020
-928.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
928.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−928.00
Price / share
—
Trade value
—
% of position
11.5%
2/11/2022
8.04K→7.11K
Total
Net shares
−928.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2022 | F · Tax Withholding | −928.00 | — | — | 11.5% | 8.04K | 7.11K |
| Total | −928.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported